CVA Family Office LLC Purchases 420 Shares of CVS Health Corporation $CVS

CVA Family Office LLC lifted its holdings in CVS Health Corporation (NYSE:CVS) by 7.9% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,756 shares of the pharmacy operator’s stock after purchasing an additional 420 shares during the period. CVA Family Office LLC’s holdings in CVS Health were worth $397,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in CVS Health by 0.8% in the first quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator’s stock worth $8,017,223,000 after acquiring an additional 969,027 shares during the period. Dodge & Cox lifted its holdings in CVS Health by 4.8% during the first quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock valued at $4,976,856,000 after purchasing an additional 3,353,223 shares in the last quarter. Invesco Ltd. boosted its holdings in CVS Health by 13.2% in the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator’s stock worth $1,383,039,000 after buying an additional 2,375,764 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of CVS Health by 14.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator’s stock valued at $1,037,205,000 after acquiring an additional 1,942,886 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of CVS Health by 5.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator’s stock worth $924,643,000 after acquiring an additional 728,924 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. UBS Group lifted their target price on CVS Health from $79.00 to $96.00 and gave the company a “buy” rating in a research note on Friday. Truist Financial set a $92.00 target price on shares of CVS Health in a report on Tuesday, October 14th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $78.00 target price on shares of CVS Health in a research note on Tuesday, August 26th. Leerink Partners boosted their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Finally, Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Sunday, September 21st. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.38.

CVS Health Price Performance

CVS stock opened at $81.95 on Friday. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $83.52. The firm has a market capitalization of $103.94 billion, a P/E ratio of 22.89, a price-to-earnings-growth ratio of 0.90 and a beta of 0.60. The company has a fifty day simple moving average of $75.57 and a two-hundred day simple moving average of $68.68. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last announced its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion for the quarter, compared to analysts’ expectations of $94.87 billion. During the same period in the prior year, the company earned $1.83 EPS. The business’s revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. CVS Health’s payout ratio is currently 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.